33487835|t|Cardiac Preconditioning Effect of Ketamine-Dexmedetomidine versus Fentanyl-Propofol during Arrested Heart Revascularization.
33487835|a|BACKGROUND: Myocardial damage due to ischemia and reperfusion is still unavoidable during coronary surgery. Anesthetic agents have myocardial preconditioning effect. Ketamine has sympathomimetic effect, while dexmedetomidine has a sympatholytic effect in addition to anesthetic, analgesic, and anti-inflammatory properties of both the drugs. This study was carried out to compare ketamine-dexmedetomidine (KD) combination with fentanyl-propofol (FP) combination on the release of cardiac troponin T (cTnT) and outcome after coronary artery bypass graft. PATIENTS AND METHODS: Ninety adult patients who underwent coronary artery bypass grafting (CABG) were assigned to receive either KD base anesthesia (KD group) or FP anesthesia (FP group). Trends of high-sensitive cTnT, CK-MB, and serum cortisol were followed in the first postoperative 24 h. Other outcomes were vital signs, weaning from cardiopulmonary bypass, tracheal extubation time, and echocardiographic findings. RESULTS: There was a significant lower release of cTnT in KD group than FP group during its peak values at 6 h after aortic unclamping (92.01 +- 7.332 in KD versus 96.73 +- 12.532 ng.L-1 P = 0.032). significant lower levels of serum cortisol levels were noted KD group than in FP group at 6 and 12 h after aortic unclamping P < 0.001. As regard tracheal extubation time, patients assigned to KD group extubated earlier than whom in FP group 202.22 +- 28.674 versus 304.67 +- 40.598 min respectively P < 0.001. CONCLUSION: The use of KD during on-pump CABG confers better myocardial protective and anti-inflammatory effect than fentanyl propofol.
33487835	34	42	Ketamine	Chemical	MESH:D007649
33487835	43	58	Dexmedetomidine	Chemical	MESH:D020927
33487835	66	83	Fentanyl-Propofol	Chemical	-
33487835	137	154	Myocardial damage	Disease	MESH:D009202
33487835	162	170	ischemia	Disease	MESH:D007511
33487835	291	299	Ketamine	Chemical	MESH:D007649
33487835	334	349	dexmedetomidine	Chemical	MESH:D020927
33487835	424	436	inflammatory	Disease	MESH:D007249
33487835	505	513	ketamine	Chemical	MESH:D007649
33487835	514	529	dexmedetomidine	Chemical	MESH:D020927
33487835	531	533	KD	Chemical	-
33487835	552	569	fentanyl-propofol	Chemical	-
33487835	571	573	FP	Chemical	-
33487835	605	623	cardiac troponin T	Gene	7139
33487835	625	629	cTnT	Gene	7139
33487835	679	687	PATIENTS	Species	9606
33487835	714	722	patients	Species	9606
33487835	808	810	KD	Chemical	-
33487835	828	830	KD	Chemical	-
33487835	841	843	FP	Chemical	-
33487835	856	858	FP	Chemical	-
33487835	892	896	cTnT	Gene	7139
33487835	915	923	cortisol	Chemical	MESH:D006854
33487835	1149	1153	cTnT	Gene	7139
33487835	1157	1159	KD	Chemical	-
33487835	1171	1173	FP	Chemical	-
33487835	1253	1255	KD	Chemical	-
33487835	1332	1340	cortisol	Chemical	MESH:D006854
33487835	1359	1361	KD	Chemical	-
33487835	1376	1378	FP	Chemical	-
33487835	1470	1478	patients	Species	9606
33487835	1491	1493	KD	Chemical	-
33487835	1531	1533	FP	Chemical	-
33487835	1632	1634	KD	Chemical	-
33487835	1701	1713	inflammatory	Disease	MESH:D007249
33487835	1726	1734	fentanyl	Chemical	MESH:D005283
33487835	1735	1743	propofol	Chemical	MESH:D015742
33487835	Negative_Correlation	MESH:D015742	MESH:D007249
33487835	Cotreatment	MESH:D007649	MESH:D020927
33487835	Negative_Correlation	MESH:D007649	7139
33487835	Negative_Correlation	MESH:D020927	MESH:D007249
33487835	Negative_Correlation	MESH:D020927	7139
33487835	Negative_Correlation	MESH:D007649	MESH:D007249

